1 completed, 1 terminated, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow Anemia, Iron Deficiency: new trials by email Literature Review of Anemia, Iron Deficiency trials Research Report on Anemia, Iron Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma Iron dextran 1000 mg IV - Anemia, Iron Deficiency, Melanoma | Phase 2 | Withdrawn | Indiana University | 2025-05-01 | 2025-07-09 | |
| Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury Iron dextran, Placebo - Anemia, Iron Deficiency, Acute Kidney Injury | Phase 2 | Completed | Hospital Civil de Guadalajara | 120 | 2023-01-06 | 2024-10-01 |
| Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia Iron sucrose, Epoetin Alfa, Placebo - Anemia, Iron Deficiency, Anemia of Chronic Disease | Phase 2 | Terminated | Unity Health Toronto | 4 | 2019-07-01 | 2021-06-18 |
Anemia, Iron-Deficiency (3) · Anemia (2) · Acute Kidney Injury (1) · Iron Deficiencies (1) · Melanoma (1)
Anemia, Hypochromic (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Iron Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Iron Deficiencies (2) · Anemia (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1)
Iron-Dextran Complex (2) · Epoetin Alfa (1) · Ferric Oxide, Saccharated (1) · Sodium Chloride (1)
Hospital Civil de Guadalajara (1) · Indiana University (1) · Unity Health Toronto (1)
Canada (1) · Mexico (1)
Gregory MT Hare, MD PhD (1) · Mateusz Oprychal, MD, PhD (1)